Related Experiment Videos
New observations on pemphigoid 'herpes' gestationis
1Department of Dermatopathology, St. Johns Institute of Dermatology, St. Thomas' Hospital, London, UK.
Dermatology (Basel, Switzerland)
|January 1, 1994
Summary
Pemphigoid gestationis (PG) is a rare pregnancy autoimmune disease. It involves immune responses in the placenta cross-reacting with skin, potentially causing fetal growth issues.
Area of Science:
- Immunodermatology
- Reproductive immunology
- Autoimmune blistering diseases
Background:
- Pemphigoid gestationis (PG) is a rare autoimmune bullous disease unique to pregnancy.
- Characterized by C3 deposition along the basal membrane zone and IgG1 antibodies.
- Associated with aberrant MHC class II expression in the placenta, triggering cross-reactivity with skin.
Purpose of the Study:
- To elucidate the immunological mechanisms underlying Pemphigoid Gestationis.
- To investigate the link between placental factors and cutaneous manifestations.
- To explore associations with HLA antigens and complement polymorphism.
Main Methods:
- Direct immunofluorescence of skin biopsies to detect C3 deposition.
- Serological analysis for circulating IgG1 antibodies and anti-HLA antibodies.
- Review of clinical outcomes including placental insufficiency and fetal growth.
Main Results:
- Linear C3 deposition at the dermal-epidermal junction in lesional and non-lesional skin.
- Presence of IgG1 antibodies and anti-HLA antibodies in affected individuals.
- Increased incidence of premature deliveries and small-for-date babies due to placental insufficiency.
- Significant association of PG with HLA antigens DR3 and DR4.
- Recent descriptions of complement polymorphism abnormalities.
Conclusions:
- PG involves a complex autoimmune response initiated in the placenta, targeting the basement membrane zone.
- The disease carries risks for pregnancy complications, including fetal growth restriction.
- Genetic factors, particularly HLA antigens and complement variations, play a role in PG pathogenesis.